Bionoid Pharma Inc. (BINP)
| Market Cap | 5.94M |
| Revenue (ttm) | 92.26K |
| Net Income (ttm) | -1.62M |
| Shares Out | 53.99M |
| EPS (ttm) | -46.27 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,500 |
| Average Volume | 33,401 |
| Open | 0.1100 |
| Previous Close | 0.1077 |
| Day's Range | 0.1100 - 0.1100 |
| 52-Week Range | 0.0220 - 0.4480 |
| Beta | -4.33 |
| RSI | 52.90 |
| Earnings Date | n/a |
About Bionoid Pharma
Bionoid Pharma Inc. engages in the hemp cultivation business. The company is based in Beverly Hills, California. [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
NEW YORK CITY, NEW YORK / ACCESS Newswire / May 16, 2025 / Bionoid Pharma Inc. (OTC PINK:BINP) proudly announces its corporate rebranding to AI Maverick Intel, Inc., marking a significant transformati...
Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit
NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its audited financial statements for t...
Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements
NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced it has engaged Aloba, Awomolo & Partners, a PCAOB-registered accounting firm, as its i...
Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced that it has submitted an application to uplist from the OTC Pink to the OTCQB Venture...
Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its financial audits for the fiscal years 2022 an...
Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025
Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to provide a corporate update as it looks ahead to a promising year in 2025. The company remains committed to its strategic growth plan, whi...
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
NEW YORK, NY / ACCESSWIRE / January 8, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over $100,000 in revenue following the signing of a Binding Lett...
Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.
NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the signing of a Binding Letter of Intent (LOI) with Vitawin Supplements Ltd. to...
AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast
NEW YORK, NY / ACCESSWIRE / November 27, 2024 / Bionoid Pharma (OTC PINK:BINP) unveils AI Maverick's game-changing sales automation in the latest episode of the BizUnLearned Podcast. Discover how this...
The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time
NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) - Bionoid Pharma, Inc. ("Bionoid") ("BINP") (OTC Pink:BINP), the new owner of the AI Maverick platfor...
Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion
TORONTO, ON / ACCESSWIRE / November 19, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is excited to announce the incorporation of its wholly owned subsidiary, Enhanced Supplements Ltd., a criti...
Bionoid Pharma, Inc. Signs Binding Letter of Intent to Acquire Main E-Commerce Platform of Your Supplement Supply Store Ltd.
TORONTO, ON / ACCESSWIRE / November 12, 2024 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is excited to announce the signing of a Binding Letter of Intent (LOI) with Your Supplement Supply Store...
Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit
TORONTO, ON and NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is pleased to announce the formal engagement of Olayinka Oyebola & Co., a PCAOB-registered ...
Bionoid Pharma, Inc. Unveils Five-Year Strategic Roadmap
AI-Driven Platform and Strategic Acquisitions to Drive Health & Wellness Growth and Profitability TORONTO, ON / ACCESSWIRE / November 5, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) has outlin...
Bionoid Pharma Inc. Provides Update on Binding Letter of Intent to Acquire Global Alerts Corp.
" Paving the Way for a Safer World Through Advanced Emergency Communications " TORONTO, ON / ACCESSWIRE / December 8, 2023 / Bionoid Pharma, Inc. ("BINP" or the "Company") (OTC PINK:BINP) is pleased t...
Bionoid Pharma Signs Exclusive License Agreement with Global Alerts Corp.
Landmark Deal Signed in Global Mass Notification Market: Exclusive License Agreement for Rapid Deployment of World-Leading Early Warning Technology TORONTO, ON / ACCESSWIRE / October 12, 2023 / Bionoi...
Bionoid Pharma Extends Letter of Intent to Acquire Global Alerts Corp.
" Paving the Way for a Safer World Through Advanced Emergency Communications " TORONTO, ON / ACCESSWIRE / August 24, 2023 / Bionoid Pharma, Inc. ("BINP" or the "Company") (OTC PINK:BINP) is pleased to...
Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.
TORONTO, ON / ACCESSWIRE / March 22, 2023 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) announced today that it has signed a Letter of Intent to acquire all the outstanding shares of Global Alerts C...